Impact of supervised injection facilities on community HIV levels: a public health perspective

References

• Tyndall MW Currie S. Spittal P, et al Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17,887–893 (2003).
   PubMed Web of Science ®Google Scholar
• ••Demonstrates the rapid transmission ofHIV in the city of Vancouver and the important role of cocaine injection.
   Google Scholar
• Nelson KE, Galai N, Safaeian M, Strathdee SA, C,elentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, USA 1988–1998. Am." Epidemiol 156(7), 641–653 (2002).
   PubMed Web of Science ®Google Scholar
• ••An epidemiologic study of how the HIVepidemic unfolded in a large US city.
   Google Scholar
• Coffin PO, Gaka S, Ahern J, Leon AC, Vlahov D, Tardiff K Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, USA 1990–1998. Addiction 98(6), 739–747 (2003).
   PubMed Web of Science ®Google Scholar
• ••A review of the important role of polydruguse in overdose deaths.
   Google Scholar
• Binswanger IA, Kral Al-I, Bluthenthal RN, Rybold DJ, Edlin BR I-ligh prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Cli,z. Infect. Dis. 30(3), 579–581 (2000).
   PubMed Web of Science ®Google Scholar
• •Shows the serious injection-related infections that occur in San Francisco, USA.
   Google Scholar
• Pakpu A, Tyndall MW, Leon H, et al Hospital utilization and costs in a cohort of injection drug users. CMAJ. 165,415–420 (2001).
   PubMed Web of Science ®Google Scholar
• Cunningham R., Walton MA, Maio RF, Blow FC, Weber JE, Mirel L Violence and substance use among an injured emergency department population. Acad. Emerg. Med 10,764–775 (2003).
   PubMed Web of Science ®Google Scholar
• Craib KJ, Spittal PM, Wood E, et al Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 168,19–24 (2003).
   PubMed Web of Science ®Google Scholar
• •Showed the increased risk of HIV infection among Aboriginal people.
   Google Scholar
• Rockwell R, Deren S, Goldstein MF, Friedman SR, Des Jarlais DC. Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?' Urban Health 79(1), 136–146 (2002).
   Google Scholar
• Strathdee SA, Patrick DM, Currie SL, et al Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11(8), F59-F65 (1997).
   PubMedGoogle Scholar
• ••Study that showed that an explosiveoutbreak of HIV infection could occur in an environment where dean needles were freely available.
   Google Scholar
• Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT. Impact of HIV infection on mortality in a cohort of injection drug users. J. Acquir. Immune Defic. Syrzdr. 28,351–357 (2001).
   PubMed Web of Science ®Google Scholar
• Palepu A, Tyndall M, Yip B, O'Shaughnessy MV, Holt RS, Montaner JS. Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J. Acquir. Immune Defic. Syrzdr. 32(5), 522–526 (2003).
   PubMed Web of Science ®Google Scholar
• Carrieri MP, Chesney MA, Spire B, Loundou A, Sobel A, Lepeu G, Moatti JP; MANIF Study Group. HAART in a cohort of French HIV-positive injecting drug users. Int. J. Behav. Med. 10(1), 1–14 (2003).
   PubMed Web of Science ®Google Scholar
• Razak MH, Jittiwutikarn J, Suriyanon V, et al HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J. Acquir. Immune Defic. Syrzdr. 33(2), 259–266 (2003).
   PubMed Web of Science ®Google Scholar
• Hamers FE Downs AM. HIV in central and eastern Europe. Lancet 361, 1035–1044 (2003).
   PubMed Web of Science ®Google Scholar
• Kelly JA, Amirkhanian YA. The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. Int. J. STD AIDS 14, 361–371 (2003).
   PubMed Web of Science ®Google Scholar
• Lowndes CM, Alaty M, Platt L Injection drug use, commercial sex work and the HIV/S1 I epidemic in the Russian Federation. Sex Transm. Dis. 30,46–48 (2003).
   PubMed Web of Science ®Google Scholar
• Lai S, Liu W Chen J, et al Changes in 1-flV-1 incidence in heroin users in Guangxi Province, China. J. Acquir. Immune DOc. Syrzdr. 26,365–370 (2001).
   PubMed Web of Science ®Google Scholar
• •An early report of the emerging injection drug related HIV epidemic in China.
   Google Scholar
• Lurie P Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 349,604–608 (1997).
   PubMed Web of Science ®Google Scholar
• Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 114,14–29 (1999).
   PubMed Web of Science ®Google Scholar
• ••An important review of the impact of drugprohibition on public health.
   Google Scholar
• Drucker E. Population impact of mass incarceration under New York's Rockefeller drug laws: an analysis of years of life lost. J. Urban Health 79(3), 434 435 (2002).
   Google Scholar
• Taylor A, Goldberg D, Emslie J, et al Outbreak of HIV infection in a Scottish prison. Br. Med. J. 310,289–292(1995).
   PubMed Web of Science ®Google Scholar
• •• An early study showing that HIV transmission can occur within the prison system.
   Google Scholar
• Wood E, Tyndall MW, Spittal PM, et al Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 16,941–943 (2002).
   PubMed Web of Science ®Google Scholar
• AlbertT,WilliamsG,RemisRetaL Canadian Policy Research Network The Economic Burden of HIV/AIDS in Canada. Renouf Publishing Co. Ltd. 1998. www.cpm.com/pubs/files/pubs-h_fhtml#eboh-s (1998, retrieved July 2003).
   Google Scholar
• Kral Al-I, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P Edlin BR Sexual transmission of 1-flV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357,1397–1401 (2001).
   PubMed Web of Science ®Google Scholar
• ••Demonstrates that sexual transmission isan important determinant of the HIV epidemic among injection drug users.
   Google Scholar
• Tyndall MW, Patrick D, Spittal P, Li K,O'Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm. Infect. 78\(Suppl. 1), 170–175 (2002).
   Google Scholar
• Wood E, Tyndall MW, Spittal PM, et al Supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CNIAJ 168,165–169 (2003).
   Google Scholar
• Wood E, Kerr T, Spittal PM, Tyndall MW O'Shaughnessy MV, Schechter MT The healthcare and fiscal costs of the illicit drug use epidemic: The impact of conventional drug control strategies and the impact of a comprehensive approach. BCMJ. 45, 130–136 (2003).
   Google Scholar
• Skolnick AA. 'Collateral casualties' climb in drug war. JAMA 271,1636–1639 (1994).
   PubMed Web of Science ®Google Scholar
• Strathdee SA, van Ameijden EJ, MesquitaF, Wodak A, Rana S, Vlahov D. Can H[V epidemics among injection drug users be prevented? AIDS 12(Suppl. A), 571-S79 (1998).
   Google Scholar
• Bluthenthal RN. Syringe exchange as a social movement: a case study of harm reduction in Oakland, California. Subst. Use Misuse 33,1147–1171 (1998).
   PubMed Web of Science ®Google Scholar
• Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 15,1329–1341 (2001).
   PubMed Web of Science ®Google Scholar
• •A thorough review of the evidence for syringe exchange in reducing HIV transmission.
   Google Scholar
• Bluthenthal RN, Kral AH, Lorvick Erringer EA, Edlin BR Harm reduction and needle exchange programmes. Lancet 13,1819–1820 (1998).
   Google Scholar
• Broadhead RS, van Hulst Y, Heckathom DD.The impact of a needle exchange's closure. Public Health Rep. 114,439–447 (1999).
   PubMed Web of Science ®Google Scholar
• Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM. Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 283, 1303–1310 (2000).
   PubMed Web of Science ®Google Scholar
• Fiellin DA, O'Connor PG, Chawarski M,Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: a randomized controlled trial. JAMA 286, 1724–1731 (2001).
   PubMed Web of Science ®Google Scholar
• Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Frautmann E Drug consumption facilities in europe and the establishment of supervised injecting centres in Australia. DrugAkohol Rev. 19, 337–346 (2000).
   Google Scholar
• •The successful operations of existing supervised injection facilities in Europe.
   Google Scholar
• Fry C, Fox S, Rumbold G. Establishing safe injecting rooms in Australia: attitudes of injecting drug users. Aust. NZ J. Public Health 23,501–504 (1999).
   PubMed Web of Science ®Google Scholar
• de Jong W, Weyer U. The professional acceptance of drug use: a closer look at drug consumption rooms in the Netherlands, Gemany and Switzerland. Inter. J Drug Polity 10,99–108 (1999).
   Google Scholar
• Dovey K, Fitzgerald J, Choi Y. Safety becomes danger: dilemmas of drug-use in public space. Health Place 7,319–331 (2001).
   PubMed Web of Science ®Google Scholar
• Broadhead RS, Kerr TH, J.P G, Altice FLSafer Injection Facilities in North America Their Place in Public Policy and Health Initiatives. J Drug Issues 32,329–355 (2002).
   Web of Science ®Google Scholar
• •A strong case for the role of supervised injection facilities in North America.
   Google Scholar
• Heimer R Can syringe exchange serve as a conduit to substance abuse treatment? J Subst. Abuse Treat. 15,183-191 (1998).
   Google Scholar
• Henderson LA, Vlahov D, C,elentano DD, Strathdee SA. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J. Acquir. Immune DOc. Syndr. 32,229–237 (2003).
   PubMed Web of Science ®Google Scholar
• •Demonstrated the important role that needle exchange programs can have on contacting injection drug users for treatment.
   Google Scholar
• Riley ED, Safaeian M, Strathdee SA, Brooner RK, Beiknson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst. Use Misuse 37,1869–1886 (2002).
   PubMed Web of Science ®Google Scholar
• Strathdee SA, C,elentano DD, Shah N, et al Needle-exchange attendance and healthcare utilization promote entry into detoxification. J Urban Health 76, 448–460 (1999).
   PubMed Web of Science ®Google Scholar
• Junge B, Valente T, Latkin C, Riley E, Vlahov D. Syringe exchange not associated with social network formation: results from Baltimore. AIDS 14,423–426 (2000).
   PubMed Web of Science ®Google Scholar
• Rockwell R, Des Jarlais DC, Friedman SR, Perlis TE, Paone D. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care 11,437-442 (1999).
   Google Scholar
• Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am. J Public Health 90,936–939 (2000).
   PubMed Web of Science ®Google Scholar
• Galea S, Ahern J, Fuller C, Freudenberg N, Vlahov D. Needle exchange programs and experience of violence in an inner city neighborhood. J. Acquir. Immune Defic. Syndr. 28,282–288 (2001).
   PubMed Web of Science ®Google Scholar
• Marx MA, Crape B, Brookmeyer RS, et al Trends in crime and the introduction of a needle exchange program. Am. J Public Health 90,1933–1936 (2000).
   PubMed Web of Science ®Google Scholar
• •Addressed the concerns that needle exchange programs create situations that increase drug related violence.
   Google Scholar
• Riley ED, Wu AW, Junge B, Marx M, Strathdee SA, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am. J. DrugAlcohol Abuse 28,497–511 (2002).
   PubMed Web of Science ®Google Scholar
• www.dniginfo.nsw.gov.au/druginfo/reports/m sic.pdf.
   Google Scholar
• Wood E, Tyndall MW Spittal PM, et al Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ 165, 405–410 (2001).
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Spittal PM, et al The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune DOc Syndr. 32,2–8 (2003).
   PubMed Web of Science ®Google Scholar
• Kerr T, Palepu A. Safe injection facilities in Canacin: is it time? CMAJ. 165,436–7 (2001).
   PubMed Web of Science ®Google Scholar
• Patrick DM, Tyndall MW Cornelisse PG, et al Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 165,889–895 (2001).
   PubMed Web of Science ®Google Scholar